PROMISE III Trial Improved Limb Salvage Outcomes

A new clinical study found a vein-arterialization procedure significantly helps patients with chronic limb-threatening ischemia.

Updated on Oct. 12, 2026 in Heart Disease

PROMISE III Trial Improved Limb Salvage Outcomes

Live Poll

Do you trust that experimental surgical techniques are safe for patients with chronic health conditions?

The PROMISE III trial demonstrated that transcatheter arterialization of the deep veins successfully improves limb salvage and reduces pain in patients. These individuals often face few options, as they are ineligible for conventional surgical or endovascular revascularization.

Why it matters

This procedure offers a critical alternative for patients facing chronic limb-threatening ischemia who cannot undergo traditional surgeries. By utilizing deep leg veins to restore blood flow, doctors can potentially prevent amputations and improve quality of life for high-risk patients.

The PROMISE III trial enrolled 100 participants, achieving a 97% technical success rate for the procedure. By the 1-year mark, overall patient survival reached 91.4% with a mean postprocedural hospital stay of 4 days.

The players

PROMISE III

This clinical trial investigated a specialized vein procedure for patients suffering from severe chronic limb-threatening ischemia.

The details

The procedure functions by diverting blood flow through deep veins in the foot, using healthy veins as conduits to deliver oxygenated blood to tissues. Data shows pain scores dropped from a mean of 6 at baseline to 0 after one year, with 91.5% of patients reporting healed or healing limbs.

3 months after the procedure, 5% of patients had fully healed wounds.
6 months after the procedure, 34% of patients had fully healed wounds.
1 year after the procedure, 64% of patients had fully healed wounds.

Health Landscape

This study signals a significant evolution in vascular medicine by providing a viable treatment path for complex cases previously considered resistant to standard intervention. The procedure marks a departure from the standard of care for chronic limb-threatening ischemia by addressing patients previously deemed inoperable.

Patients suffering from severe ischemia who previously lacked surgical options may now have access to a procedure that reduces pain and promotes limb healing. Consultation with a vascular specialist is necessary to determine if this approach is suitable for specific health profiles, including patients currently on dialysis.

The takeaway

The PROMISE III results suggest that even for patients ineligible for conventional surgery, advanced venous techniques can offer life-changing results. Maintaining regular follow-ups with medical providers remains the best way to monitor vascular health and healing progress.